"Hemangioendothelioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
| Descriptor ID |
D006390
|
| MeSH Number(s) |
C04.557.645.375.370
|
| Concept/Terms |
Hemangioendothelioma- Hemangioendothelioma
- Hemangioendotheliomas
- Endothelioma, Vascular
- Endotheliomas, Vascular
- Vascular Endothelioma
- Vascular Endotheliomas
- Hemangio-Endothelioma
- Hemangio Endothelioma
- Hemangio-Endotheliomas
|
Below are MeSH descriptors whose meaning is more general than "Hemangioendothelioma".
Below are MeSH descriptors whose meaning is more specific than "Hemangioendothelioma".
This graph shows the total number of publications written about "Hemangioendothelioma" by people in this website by year, and whether "Hemangioendothelioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemangioendothelioma" by people in Profiles.
-
Incidence, demographics, and survival of malignant hemangioendothelioma in the United States. Cancer Med. 2023 07; 12(14):15101-15106.
-
Management of Vascular Sarcoma. Surg Oncol Clin N Am. 2022 07; 31(3):485-510.
-
How we approach the diagnosis of a vascular anomaly. Pediatr Blood Cancer. 2022 08; 69 Suppl 3:e29802.
-
Cellular variant of kaposiform lymphangiomatosis: a report of three cases, expanding the morphologic and molecular genetic spectrum of this rare entity. Hum Pathol. 2022 04; 122:72-81.
-
Long-term outcomes of pediatric and young adult patients receiving radiotherapy for nonmalignant vascular anomalies. Pediatr Blood Cancer. 2021 06; 68(6):e28955.
-
Vascular tumors. Semin Pediatr Surg. 2020 Oct; 29(5):150975.
-
Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. J Pediatr. 2018 12; 203:294-300.e2.
-
Refractory Kaposiform Hemangioendothelioma Associated with the Chromosomal Translocation t(13;16)(q14;p13.3). Pediatr Dev Pathol. 2016 Sep/Oct; 19(5):417-420.
-
Incidental simultaneous finding of intravascular histiocytosis and reactive angioendotheliomatosis: a case report. Am J Dermatopathol. 2015 May; 37(5):401-4.
-
Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms. Clin Imaging. 2015 May-Jun; 39(3):529-32.